-
1061
Computational Methods to Work as First-Pass Filter in Deleterious SNP Analysis of Alkaptonuria
Published 2012-01-01Get full text
Article -
1062
-
1063
-
1064
Rethinking scabies in Europe: An ECDC prevention framework approach
Published 2025-01-01Get full text
Article -
1065
Gut Microorganism-Mediated Neutralization of Mycotoxins: A Promising Approach to Combat Fungal Toxicity
Published 2024-01-01Get full text
Article -
1066
-
1067
-
1068
Resistance mechanisms to immune checkpoint inhibitors: updated insights
Published 2025-01-01Get full text
Article -
1069
Mucinous Colorectal Carcinoma in a 17-Year-Old Male: A Diagnosis with Low Clinical Index of Suspicion
Published 2019-01-01Get full text
Article -
1070
Poly(3-hydroxybutyrate): Promising biomaterial for bone tissue engineering
Published 2020-03-01Get full text
Article -
1071
Research on the Compilation of Mechanical Design Guided Textbooks Based on Chinese University MOOCs
Published 2024-01-01Get full text
Article -
1072
-
1073
Isolated Kaposi Sarcoma of the Tonsil: A Case Report and Review of the Scientific Literature
Published 2015-01-01Get full text
Article -
1074
Neuroinflammation and Cerebrovascular Disease in Old Age: A Translational Medicine Perspective
Published 2011-01-01Get full text
Article -
1075
Mechanisms underlying CSD initiation implicated by genetic mouse models of migraine
Published 2025-01-01Get full text
Article -
1076
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
Published 2025-01-01“…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
Get full text
Article -
1077
Review of Challenges in Performing Real-World Evidence Studies for Nonprescription Products
Published 2025-01-01“…Christian Maihöfner,1 Theresa Mallick-Searle,2 Jan Vollert,3 Pranab Kalita,4 Vidhu Sood Sethi5 1Department of Neurology, General Fürth Hospital, University of Erlangen, Fürth, Germany; 2Division of Pain Medicine, Stanford Health Care Pain Management Clinic, Palo Alto, CA, USA; 3Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK; 4Global Category Medical Affairs, Haleon Plc, Weybridge, England, UK; 5Global Medical Affairs, GSK Consumer Healthcare Singapore Pte. …”
Get full text
Article -
1078
Dynamic hierarchical ligand anisotropy for competing macrophage regulation in vivo
Published 2025-05-01Get full text
Article -
1079
A deep learning-based ADRPPA algorithm for the prediction of diabetic retinopathy progression
Published 2024-12-01Get full text
Article -
1080